{"meta":{"query_hash":"47f3a50fd825","filters":{"venue":"Molecular Therapy — Oncolytics"},"cohort_total":44,"direct_labels_cover":0,"predictions_cover":44,"exported":44,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/47f3a50fd825","api":"https://metacan.xera.ac/api/v1/cohort?venue=Molecular+Therapy+%E2%80%94+Oncolytics"},"results":[{"id":"W2315750663","doi":"10.1038/mto.2015.4","title":"Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"McMaster University; Canadian Cancer Society Research Institute; Cancer Research Society; Breast Cancer Alliance; Cancer Research Institute","keywords":"Oncolytic virus; Cancer research; Biology; Breast cancer; In vivo; Oncolytic adenovirus; Cancer; Cytotoxicity; Cancer cell; Adenocarcinoma; Immunology; Immune system; In vitro","score_opus":0.029029646094145056,"score_gpt":0.29353872021829164,"score_spread":0.2645090741241466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315750663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386,0.0016691103,0.0018692496,0.00022720319,0.000106419975,0.00013151419,0.0003198992,0.00023496644,0.00158169],"genre_scores_gemma":[0.9909725,0.0014329221,0.0026712515,0.000058407124,0.000034352775,0.00016923145,0.0004015896,0.00004353898,0.0042162277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961287,0.00010238586,0.000029419178,0.000075273674,0.00007199556,0.00010813132],"domain_scores_gemma":[0.99966395,0.000052939657,0.00007234158,0.000064470674,0.000028246062,0.0001181208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045124374,0.0010017343,0.000784688,0.00093803165,0.00029173616,0.00040335002,0.0005802286,0.00056961464,0.0015242521],"category_scores_gemma":[0.00018979647,0.0003090361,0.0005583809,0.0003734476,0.000522426,0.00051905646,0.0003025191,0.0014534503,0.00042797215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024822757,0.0011055432,0.00022973656,0.00009273171,0.000023812838,0.00013829733,0.00006545393,0.00029138746,0.9906399,0.00022998976,0.00014066542,0.0045600897],"study_design_scores_gemma":[0.000277334,0.01942977,0.0019735792,0.000013110711,0.00008027837,0.0005102208,0.00006262947,0.0015857124,0.9733011,0.00007534784,0.0026704113,0.000020525928],"about_ca_topic_score_codex":0.002860303,"about_ca_topic_score_gemma":0.0032510322,"teacher_disagreement_score":0.002860303,"about_ca_system_score_codex":0.0006195333,"about_ca_system_score_gemma":0.00066381344,"threshold_uncertainty_score":0.0056872964},"labels":[],"label_agreement":null},{"id":"W2316138506","doi":"10.1038/mto.2016.5","title":"N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Alberta Children's Hospital; Ontario Institute for Cancer Research; Alberta Cancer Foundation; University of Calgary","funders":"Cancer Research Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Vesicular Stomatitis; Neuroblastoma; Virology; Cancer research; Vesicular stomatitis Indiana virus; Virus; Biology; Cell culture; Genetics","score_opus":0.008328318019166765,"score_gpt":0.2785129837965683,"score_spread":0.2701846657774015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316138506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997214,0.00089123414,0.0007657722,0.000027623155,0.00001268127,0.000017625065,0.00031200476,0.00001762821,0.00074138906],"genre_scores_gemma":[0.99540603,0.0006961098,0.0015286277,0.000020593576,0.000004412369,0.000027606065,0.00053028145,0.0000079102665,0.0017785197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998864,0.000018061166,0.000014442499,0.00002537035,0.0000349461,0.000020829195],"domain_scores_gemma":[0.99994576,0.000014342702,0.000009670915,0.000008498523,0.000010099063,0.000011569185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013574699,0.00019543192,0.00022337674,0.00013084114,0.00009760216,0.00019868767,0.0000865731,0.00013698853,0.0005659274],"category_scores_gemma":[0.00009711123,0.000092018716,0.000188892,0.00012395285,0.00010399831,0.00012304925,0.0001502503,0.0002723332,0.00018183685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058022208,0.000017381912,0.00017522644,0.000018591352,0.0000027081942,0.000012134321,0.00001192142,0.000053290856,0.9991047,0.000019183444,0.000013443093,0.0005133698],"study_design_scores_gemma":[0.000008049648,0.00040372778,0.008229794,0.000005175945,0.000015003627,0.00009736681,0.000030821426,0.0012884419,0.98829985,0.000021256514,0.0015970159,0.0000035236671],"about_ca_topic_score_codex":0.0014787158,"about_ca_topic_score_gemma":0.0023084634,"teacher_disagreement_score":0.0014787158,"about_ca_system_score_codex":0.00024957611,"about_ca_system_score_gemma":0.00015840027,"threshold_uncertainty_score":0.0029402375},"labels":[],"label_agreement":null},{"id":"W2412847484","doi":"10.1038/mto.2016.1","title":"Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Vesicular stomatitis virus; Oncolytic virus; Virology; Interferon; Stomatitis; Vesicular Stomatitis; Vesicular stomatitis Indiana virus; Virus; Medicine; Cancer research; Internal medicine","score_opus":0.03397533768895688,"score_gpt":0.3126975296336064,"score_spread":0.27872219194464953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412847484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898315,0.0029768634,0.004736049,0.000120026634,0.00005647844,0.000039638493,0.00018730605,0.00008336757,0.0019688236],"genre_scores_gemma":[0.9946391,0.00078466185,0.0029741195,0.00005023467,0.000014246858,0.0000248948,0.0002827653,0.000013411078,0.0012166991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987197,0.00002091975,0.000012326479,0.00002235049,0.00003941856,0.0000330616],"domain_scores_gemma":[0.9999043,0.000028865756,0.000025016894,0.000011768682,0.000011870401,0.00001816302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018316107,0.00035087854,0.0003305338,0.00023693305,0.00006646607,0.0002558159,0.00011911021,0.0003696261,0.00051865535],"category_scores_gemma":[0.00013009197,0.00009139467,0.0002558105,0.0001777387,0.00017252946,0.00017220632,0.00011685659,0.00049237267,0.00016962379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104415776,0.000033106433,0.00008638599,0.000023048558,0.0000050433523,0.000022492213,0.000007809212,0.00015236367,0.9972531,0.000091147514,0.00003275698,0.002188353],"study_design_scores_gemma":[0.00002533786,0.0008248978,0.001176529,0.0000053021463,0.000021705673,0.00021662816,0.0000056048093,0.0013150501,0.9943334,0.00005196939,0.0020196482,0.000003927922],"about_ca_topic_score_codex":0.00027720357,"about_ca_topic_score_gemma":0.0002586512,"teacher_disagreement_score":0.00051865535,"about_ca_system_score_codex":0.00025362725,"about_ca_system_score_gemma":0.00016552077,"threshold_uncertainty_score":0.0018402338},"labels":[],"label_agreement":null},{"id":"W2416659570","doi":"10.1038/mto.2015.14","title":"Chimeric antigen receptor–engineered T cells as oncolytic virus carriers","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Chimeric antigen receptor; Adoptive cell transfer; Virus; Immune system; Antigen; Cancer research; Antibody; Immunology; Receptor; Biology; Immunotherapy; Virology; T cell","score_opus":0.035945221340119994,"score_gpt":0.3239435815978033,"score_spread":0.2879983602576833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416659570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8541168,0.021359587,0.115643136,0.00043464356,0.00037256238,0.0005396217,0.00041433715,0.00063513103,0.0064842016],"genre_scores_gemma":[0.9651944,0.0044526737,0.026711678,0.0001259977,0.00003859122,0.00017961112,0.00028257605,0.000053461823,0.00296102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997265,0.00009171537,0.000016461547,0.00004128443,0.00006597347,0.00005808706],"domain_scores_gemma":[0.99992585,0.00001855514,0.000022165234,0.0000102229915,0.000011059678,0.000012064793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002859091,0.00039091078,0.00024815105,0.000286818,0.000079667465,0.00042010844,0.00038227713,0.0006038647,0.00069065107],"category_scores_gemma":[0.00020297378,0.0001879022,0.00031965767,0.00018695912,0.00024420186,0.0003717014,0.0002632245,0.0007021754,0.00050165656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013737923,0.00006272864,0.00008670401,0.0001042355,0.000015810527,0.00007694189,0.000028511784,0.0010302835,0.989753,0.0011086487,0.00023510496,0.007360678],"study_design_scores_gemma":[0.000111803056,0.0012255987,0.00032951517,0.000020687543,0.00005045249,0.0005400975,0.00001777106,0.0071875844,0.97462547,0.00036268626,0.015513373,0.000015007035],"about_ca_topic_score_codex":0.00035428753,"about_ca_topic_score_gemma":0.0002760718,"teacher_disagreement_score":0.00069065107,"about_ca_system_score_codex":0.00024597684,"about_ca_system_score_gemma":0.00021204562,"threshold_uncertainty_score":0.0023103952},"labels":[],"label_agreement":null},{"id":"W2468950574","doi":"10.1038/mto.2016.17","title":"Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke","keywords":"Genetic enhancement; Cancer research; Adeno-associated virus; Brain tumor; Biology; Reporter gene; Systemic administration; Transgene; Viral vector; Gene delivery; Vector (molecular biology); Immunology; Pathology; Molecular biology; Gene; Gene expression; Medicine; In vivo; Recombinant DNA","score_opus":0.021114307487250156,"score_gpt":0.2848859474876812,"score_spread":0.2637716400004311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468950574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926051,0.0009969485,0.0045047803,0.00009139562,0.000048024925,0.000072609924,0.00020230858,0.00022172555,0.0012571365],"genre_scores_gemma":[0.9922902,0.0011830392,0.0032222944,0.000033403427,0.000012187352,0.00006104599,0.00040964203,0.000040407856,0.0027477932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989617,0.000013826166,0.000007787996,0.000026477075,0.00002832109,0.000027448512],"domain_scores_gemma":[0.9999429,0.0000061781802,0.000017474978,0.000008746982,0.0000085971515,0.000016052727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017242829,0.0004757568,0.0005488942,0.00024083637,0.00010965938,0.00030731704,0.00015999185,0.0002444187,0.0009287901],"category_scores_gemma":[0.00006322895,0.00013526052,0.00024194777,0.00014436939,0.00016646711,0.00020680485,0.00013469074,0.0006818813,0.00026483356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017807052,0.00022083384,0.0002694275,0.000042546806,0.000012565183,0.00007437943,0.000034518438,0.0001729786,0.9952833,0.0001038791,0.00014013138,0.0034672813],"study_design_scores_gemma":[0.00006332227,0.0062974705,0.0041169007,0.000011561586,0.000069402995,0.00080166373,0.00007508592,0.0029642703,0.9817346,0.00007098477,0.0037848565,0.000009844649],"about_ca_topic_score_codex":0.0015112624,"about_ca_topic_score_gemma":0.002728311,"teacher_disagreement_score":0.0015112624,"about_ca_system_score_codex":0.00022254384,"about_ca_system_score_gemma":0.00037431484,"threshold_uncertainty_score":0.0031071305},"labels":[],"label_agreement":null},{"id":"W2469820651","doi":"10.1038/mto.2015.13","title":"Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Ovarian Cancer Canada; Cancer Care Ontario; Western University","funders":"","keywords":"Oncolytic virus; Myxoma virus; Ovarian cancer; Virus; Biology; Metastasis; Vaccinia; Cancer research; Cancer cell; Virology; Spheroid; Cell culture; Cancer","score_opus":0.12241179232364242,"score_gpt":0.3962003653944838,"score_spread":0.27378857307084137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469820651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921951,0.001471772,0.00487386,0.00007578739,0.00004422934,0.000040157287,0.0002838973,0.000058032398,0.00095712877],"genre_scores_gemma":[0.9935963,0.0007941214,0.003563502,0.00002759101,0.00001271832,0.000055086977,0.00049442647,0.000020900008,0.0014353683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996152,0.00012407554,0.000049748756,0.000052323234,0.00010433541,0.00005424456],"domain_scores_gemma":[0.9995664,0.00019175159,0.00007088567,0.000066596505,0.00005554231,0.000048803453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031185526,0.00035437653,0.00040158478,0.00032926537,0.0002365714,0.00042086176,0.00021739285,0.00030611406,0.00071140454],"category_scores_gemma":[0.0003798159,0.00018229411,0.0003024741,0.000173956,0.00026997906,0.0003055452,0.00026653378,0.0009012153,0.00019438025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041005755,0.000040838568,0.00019606418,0.000027718112,0.00000430219,0.000018336652,0.000026407193,0.00006357864,0.99914587,0.00007787196,0.000016112695,0.0003419751],"study_design_scores_gemma":[0.0000071415407,0.0006856598,0.0023483322,0.00000317157,0.000012832969,0.00014119197,0.000028404878,0.0012173452,0.99492955,0.000035618967,0.0005870509,0.0000037168452],"about_ca_topic_score_codex":0.0021048347,"about_ca_topic_score_gemma":0.0018406784,"teacher_disagreement_score":0.0021048347,"about_ca_system_score_codex":0.0003537494,"about_ca_system_score_gemma":0.00022515663,"threshold_uncertainty_score":0.00418514},"labels":[],"label_agreement":null},{"id":"W2550160905","doi":"10.1038/mto.2016.27","title":"Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Children's Hospital of Eastern Ontario; University of Toronto; University Health Network; Ottawa Hospital; University of Ottawa; Ontario Institute for Cancer Research","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Lymphocytic choriomeningitis; Virology; Antibody; Virus; Biology; Neutralizing antibody; Arenavirus; Glycoprotein; Oncolytic virus; Immune system; Neutralization; Immunology; Molecular biology","score_opus":0.043154517025019004,"score_gpt":0.33702531308301475,"score_spread":0.29387079605799576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550160905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98383915,0.001181905,0.010600355,0.0001574679,0.000039583632,0.00007585311,0.00021248894,0.00017552028,0.0037176749],"genre_scores_gemma":[0.9912742,0.00048207399,0.005132701,0.0000381295,0.000007682581,0.000050949584,0.00017851476,0.00002397767,0.0028118673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998171,0.000020062198,0.000009591018,0.000040659073,0.00006248555,0.000050217215],"domain_scores_gemma":[0.99991024,0.000018101413,0.000028274748,0.0000128346355,0.000011767149,0.000018790171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101886966,0.0003363714,0.00014598433,0.00018847191,0.00015997858,0.0002572354,0.00020857103,0.00033241248,0.0010320831],"category_scores_gemma":[0.00011482262,0.00010146802,0.00016801074,0.00012452957,0.0002361518,0.00021935944,0.00022484451,0.0005173378,0.00023523583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030191117,0.000011396828,0.000026848695,0.000008755727,0.0000013697357,0.000019232562,0.000008463816,0.00007629591,0.9989668,0.00021974531,0.00002290563,0.0006078262],"study_design_scores_gemma":[0.000005923728,0.00015017064,0.0002847741,0.0000018841707,0.00000464415,0.00007196984,0.000004235311,0.0010341597,0.9969599,0.000041458283,0.001438345,0.0000025606228],"about_ca_topic_score_codex":0.0026211317,"about_ca_topic_score_gemma":0.0030951558,"teacher_disagreement_score":0.0026211317,"about_ca_system_score_codex":0.00055281684,"about_ca_system_score_gemma":0.00039752258,"threshold_uncertainty_score":0.005211711},"labels":[],"label_agreement":null},{"id":"W2744993513","doi":"10.1016/j.omto.2017.08.001","title":"Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Beatrice Hunter Cancer Research Institute","keywords":"Oncolytic virus; Virotherapy; Vesicular stomatitis virus; Virology; Vesicular Stomatitis; Virus; Biology; Cancer research; Medicine","score_opus":0.023725987008250304,"score_gpt":0.30508686484796516,"score_spread":0.28136087783971486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744993513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941789,0.0009263018,0.0029225901,0.00006902333,0.000050249506,0.00012269727,0.0003362484,0.00015633914,0.0012376524],"genre_scores_gemma":[0.99189633,0.00074915565,0.003315727,0.000025692163,0.000012449454,0.00010820674,0.00048747277,0.00003632226,0.0033687116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998178,0.000025669407,0.000010660226,0.000035746412,0.00005107611,0.000059029193],"domain_scores_gemma":[0.9999076,0.000012886482,0.00001739837,0.000010485793,0.000013608593,0.00003805198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018353084,0.0005997676,0.00051835016,0.00046247966,0.00015312155,0.0003224325,0.00026711123,0.00032635208,0.0009723368],"category_scores_gemma":[0.00009984773,0.00017489602,0.00043732589,0.00018256025,0.00021266744,0.00025618298,0.0002013362,0.00077915186,0.00020978367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003382791,0.00020133755,0.00010010541,0.000038319013,0.000010241178,0.000037753114,0.000019906714,0.0003112402,0.9970822,0.00011006294,0.00008578416,0.0016647981],"study_design_scores_gemma":[0.00004373869,0.0017462798,0.0010081572,0.000003943114,0.000030495388,0.00013619073,0.000012702504,0.00195746,0.994041,0.000039988638,0.0009755351,0.0000046026794],"about_ca_topic_score_codex":0.0018610248,"about_ca_topic_score_gemma":0.002610695,"teacher_disagreement_score":0.0018610248,"about_ca_system_score_codex":0.00058223814,"about_ca_system_score_gemma":0.00039166617,"threshold_uncertainty_score":0.0042244196},"labels":[],"label_agreement":null},{"id":"W2756406213","doi":"10.1016/j.omto.2017.09.004","title":"Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Wilfrid Laurier University; Ottawa Hospital; Children's Hospital of Eastern Ontario","funders":"National Cancer Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Virus; Virotherapy; Medicine; Immunology; Immune system; Virology","score_opus":0.01909480124259364,"score_gpt":0.32994100818512667,"score_spread":0.310846206942533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756406213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986251,0.0011834028,0.010984772,0.0001391837,0.000024483532,0.000035309753,0.00008890112,0.00013787541,0.0011551016],"genre_scores_gemma":[0.9927729,0.0008723658,0.005315972,0.000026900883,0.0000088239885,0.000023203747,0.00008130773,0.000013577366,0.0008849985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999342,0.0000118714015,0.0000053588874,0.00001738951,0.000012303122,0.000018888253],"domain_scores_gemma":[0.9999651,0.000005400168,0.0000107832675,0.0000072709768,0.000003646299,0.000007815065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015286043,0.00029438178,0.00022402855,0.0001284213,0.0001068786,0.00027116443,0.0001116236,0.00016375285,0.0008054271],"category_scores_gemma":[0.000080926955,0.00007838719,0.00012959486,0.00007025487,0.00032676395,0.00023724294,0.0002033876,0.00056780444,0.00020797193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043755594,0.000015492265,0.00005633422,0.000015774276,0.0000017542559,0.000010412647,0.0000074272466,0.00008085396,0.9975206,0.00022700222,0.000020221107,0.0020003351],"study_design_scores_gemma":[0.000010576635,0.00032180958,0.00048034234,0.0000054746615,0.000007816383,0.00013155802,0.000008541141,0.0005760376,0.99728405,0.000099485966,0.001072264,0.0000019700435],"about_ca_topic_score_codex":0.0002715836,"about_ca_topic_score_gemma":0.0005759875,"teacher_disagreement_score":0.0008054271,"about_ca_system_score_codex":0.0002113571,"about_ca_system_score_gemma":0.00032380119,"threshold_uncertainty_score":0.002694428},"labels":[],"label_agreement":null},{"id":"W2756920003","doi":"10.1016/j.omto.2017.08.004","title":"Infectious Optimism following the 10th International Oncolytic Virus Meeting","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Ottawa Hospital; McMaster University","funders":"","keywords":"Oncolytic virus; Optimism; Commercialization; Coronavirus disease 2019 (COVID-19); Medicine; Political science; Virus; Virology; Psychology; Infectious disease (medical specialty); Pathology","score_opus":0.022831408473286168,"score_gpt":0.3364568364062731,"score_spread":0.3136254279329869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756920003","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016042756,0.10834726,0.007713626,0.5164554,0.28572553,0.000150812,0.0005274583,0.0002009091,0.06483622],"genre_scores_gemma":[0.21145175,0.122001395,0.008447745,0.13915043,0.09730732,0.00032112756,0.0014097882,0.0004862554,0.41942415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971764,0.000792894,0.00011743086,0.00027471856,0.00100783,0.00063067966],"domain_scores_gemma":[0.996185,0.00075783505,0.00019686687,0.00008578686,0.0014512916,0.0013231697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009335503,0.0007094341,0.00038208056,0.000616459,0.0024221174,0.009535528,0.0007931934,0.0051983534,0.00786599],"category_scores_gemma":[0.009155289,0.00035112095,0.00066186016,0.0004900997,0.0014904814,0.0025301084,0.002198482,0.008269881,0.0032768832],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006379577,0.0001684602,0.0010917141,0.0004399954,0.00006497265,0.0007466267,0.0015982654,0.0006422201,0.005422819,0.035753503,0.8441712,0.109262295],"study_design_scores_gemma":[0.000019207046,0.00011158315,0.00072023785,0.00012574738,0.000019634306,0.00012801029,0.0004654014,0.00014094917,0.0022797256,0.0031281125,0.9928351,0.000026285288],"about_ca_topic_score_codex":0.0052793804,"about_ca_topic_score_gemma":0.0128370905,"teacher_disagreement_score":0.009535528,"about_ca_system_score_codex":0.006933311,"about_ca_system_score_gemma":0.0066164397,"threshold_uncertainty_score":0.05030495},"labels":[],"label_agreement":null},{"id":"W2801932471","doi":"10.1016/j.omto.2018.04.002","title":"Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Deutsche Krebshilfe","keywords":"Oncolytic virus; Measles virus; Virology; Measles; microRNA; Virus; Medicine; Biology; Vaccination; Gene; Genetics","score_opus":0.02540920253507335,"score_gpt":0.32057624237234045,"score_spread":0.2951670398372671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801932471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655568,0.0011960011,0.030895218,0.00007551145,0.000052778014,0.00007063132,0.00019545428,0.00026149538,0.0016960265],"genre_scores_gemma":[0.978442,0.00037365162,0.018972466,0.000020118265,0.00000682588,0.00003731739,0.0002641488,0.000061014933,0.0018223226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996394,0.00007286144,0.000048759845,0.000090345195,0.000108132546,0.000040519164],"domain_scores_gemma":[0.99977,0.00004870686,0.00009211347,0.000033384873,0.00002787137,0.00002789658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030550762,0.00041903267,0.00022602905,0.00017089379,0.00013636998,0.00041074303,0.0003085336,0.00033001963,0.0008230869],"category_scores_gemma":[0.00028890817,0.0001881001,0.00031589647,0.00013586665,0.00029100166,0.00019542522,0.000335067,0.00063476554,0.00037149005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032446875,0.0000066120865,0.00004204704,0.00001541524,0.000002191007,0.000009728308,0.0000062243007,0.000055426084,0.9989693,0.000154022,0.000006288122,0.00070042996],"study_design_scores_gemma":[0.0000025660063,0.000044555527,0.00009924483,8.4094756e-7,0.0000032638159,0.000034944627,0.0000016416615,0.00029328704,0.9990465,0.000016147349,0.0004555783,0.0000014767804],"about_ca_topic_score_codex":0.000286229,"about_ca_topic_score_gemma":0.00042284656,"teacher_disagreement_score":0.0008230869,"about_ca_system_score_codex":0.00043566004,"about_ca_system_score_gemma":0.00031065554,"threshold_uncertainty_score":0.0031610131},"labels":[],"label_agreement":null},{"id":"W2809465143","doi":"10.1016/j.omto.2018.06.002","title":"Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Health Canada; Fondation Brain Canada; Cancer Research Institute; Ocean Reef Community Foundation","keywords":"Oncolytic virus; Vesicular stomatitis virus; Tumor necrosis factor alpha; Proinflammatory cytokine; Medicine; Inhibitor of apoptosis; Cancer research; Immunology; Innate immune system; Apoptosis; Cytokine; Immune system; Cancer; Programmed cell death; Virology; Virus; Biology; Inflammation; Internal medicine","score_opus":0.022894667437807166,"score_gpt":0.32186215139592295,"score_spread":0.2989674839581158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809465143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223375,0.0021997243,0.003223757,0.00008555921,0.00008344901,0.00006735823,0.00017073657,0.00010358156,0.001831958],"genre_scores_gemma":[0.99444383,0.00083036954,0.0022428844,0.000034262688,0.000018793662,0.000057170284,0.00026194504,0.000012843646,0.002097973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998679,0.00002171392,0.000013701277,0.000023964212,0.000030809708,0.00004193934],"domain_scores_gemma":[0.9999331,0.000011144005,0.000016747712,0.000011362489,0.000006369367,0.000021363041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118911725,0.0003348224,0.0003383447,0.0002127019,0.00008085244,0.00022737785,0.00016784981,0.00022055884,0.0006724262],"category_scores_gemma":[0.000078692836,0.00010735939,0.00026558278,0.00014188084,0.00012399328,0.00014461506,0.00014860323,0.0006174913,0.00023336492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039495138,0.00016373559,0.00017151522,0.000039622162,0.000014325678,0.00003664573,0.000012604854,0.00023900121,0.9937358,0.00014338082,0.00011030009,0.0049381074],"study_design_scores_gemma":[0.000050273844,0.0015133179,0.0010626989,0.000004604471,0.000023505196,0.00017870533,0.000008381204,0.0015396366,0.9930472,0.0000291852,0.002539491,0.0000029719913],"about_ca_topic_score_codex":0.0003131065,"about_ca_topic_score_gemma":0.00046321872,"teacher_disagreement_score":0.0006724262,"about_ca_system_score_codex":0.0001959869,"about_ca_system_score_gemma":0.00021483857,"threshold_uncertainty_score":0.0022494793},"labels":[],"label_agreement":null},{"id":"W2882978751","doi":"10.1016/j.omto.2018.06.001","title":"Visualizing Oncolytic Virus-Host Interactions in Live Mice Using Intravital Microscopy","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"Canadian Cancer Society Research Institute; U.S. Food and Drug Administration; Alberta Children's Hospital Foundation; Canada Research Chairs","keywords":"Oncolytic virus; Vesicular stomatitis virus; Intravital microscopy; Virus; Biology; Context (archaeology); Spleen; Virology; Alexa Fluor; Cell biology; In vivo; Immunology","score_opus":0.03640351332765523,"score_gpt":0.39077307762313984,"score_spread":0.3543695642954846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2882978751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8474408,0.0033566013,0.13673194,0.00059708225,0.000103848026,0.0002346737,0.0015548337,0.0011988755,0.008781355],"genre_scores_gemma":[0.84596246,0.002439487,0.13653943,0.00025855654,0.000040999417,0.0005129443,0.0009407688,0.00030348048,0.01300176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981374,0.000025346306,0.000009589723,0.000048894875,0.000033011347,0.000069517235],"domain_scores_gemma":[0.9998497,0.00004933732,0.000034847573,0.000019141917,0.000019661298,0.00002731956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033414314,0.0005467729,0.00026129367,0.0006192476,0.00035956796,0.00047213852,0.000454565,0.0007525567,0.0015536153],"category_scores_gemma":[0.00014064109,0.000320283,0.00027643185,0.00020331239,0.00030809827,0.0004055668,0.00041981574,0.0015641364,0.00044113013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030141171,0.000028478742,0.00011607847,0.000022873035,0.0000040427904,0.000034858163,0.00002395828,0.00017322399,0.997866,0.0004848095,0.00005864836,0.0011569624],"study_design_scores_gemma":[0.000022576034,0.00024365402,0.002516618,0.000017797529,0.00001899643,0.0002586903,0.000044139342,0.009088174,0.9830921,0.00038483602,0.004300393,0.000012033148],"about_ca_topic_score_codex":0.002371007,"about_ca_topic_score_gemma":0.0027629042,"teacher_disagreement_score":0.002371007,"about_ca_system_score_codex":0.000623788,"about_ca_system_score_gemma":0.0003965427,"threshold_uncertainty_score":0.005197406},"labels":[],"label_agreement":null},{"id":"W2888927593","doi":"10.1016/j.omto.2018.08.003","title":"APOBEC3 Mediates Resistance to Oncolytic Viral Therapy","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Rosetrees Trust; Richard M. Schulze Family Foundation; Mayo Foundation for Medical Education and Research; University of Minnesota; Mayo Clinic","keywords":"Oncolytic virus; Vesicular stomatitis virus; Biology; Virotherapy; Gene knockdown; Virology; Virus; Cancer cell; Interferon; Cancer research; Cell culture; Cancer; Genetics","score_opus":0.0205703581799672,"score_gpt":0.3219701523271543,"score_spread":0.3013997941471871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888927593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967986,0.013691421,0.0056407647,0.00075303315,0.00008427975,0.00007268466,0.00033843136,0.0003144078,0.011119046],"genre_scores_gemma":[0.9956528,0.0010525623,0.00044570482,0.00009650555,0.000009667914,0.0000120545155,0.000119390264,0.000011085629,0.0026002447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998795,0.000018180262,0.0000062645568,0.000021765652,0.00003716542,0.000037018544],"domain_scores_gemma":[0.9999181,0.000016980575,0.000021216696,0.000010137148,0.000015791935,0.00001781349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012775882,0.00017687344,0.00015487615,0.0001202081,0.0001847363,0.00037841234,0.00014992787,0.00051611953,0.0015518699],"category_scores_gemma":[0.0001767448,0.000085247586,0.00017207173,0.00008648266,0.00020445406,0.00017325678,0.00021649968,0.0008189919,0.00042424595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010533052,0.00002391258,0.0008098665,0.000051070794,0.000007926412,0.00017958002,0.000029820314,0.000118173324,0.9933066,0.00046837048,0.0003028996,0.0045964485],"study_design_scores_gemma":[0.000055497218,0.00050057226,0.022694485,0.000035479286,0.00003642899,0.0026651232,0.0001031127,0.0054294337,0.9405817,0.0009472677,0.0269286,0.000022194812],"about_ca_topic_score_codex":0.0027416225,"about_ca_topic_score_gemma":0.0021223985,"teacher_disagreement_score":0.0027416225,"about_ca_system_score_codex":0.00063096493,"about_ca_system_score_gemma":0.00025769617,"threshold_uncertainty_score":0.005451381},"labels":[],"label_agreement":null},{"id":"W2892207721","doi":"10.1016/j.omto.2018.09.002","title":"Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina; Consejo Superior de Investigaciones Científicas; Ministerio de Economía y Competitividad; Universidad de Málaga; Canadian Institute of Steel Construction; Universitat de Barcelona; Ministerio de Ciencia e Innovación","keywords":"Bystander effect; Glioblastoma; Medicine; Oncology; Cancer research; Immunology","score_opus":0.01404069675444263,"score_gpt":0.27276433393962607,"score_spread":0.25872363718518343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892207721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64709044,0.21931861,0.109761894,0.008042485,0.00068056496,0.00055578526,0.0011870124,0.0015140082,0.011849144],"genre_scores_gemma":[0.8198991,0.1169222,0.050669678,0.001032483,0.00035604768,0.00024797057,0.0008217294,0.00014926564,0.009901647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980134,0.000041717994,0.0000120450695,0.000029656469,0.00007566757,0.00003960402],"domain_scores_gemma":[0.99991107,0.000013954216,0.000021873484,0.000010527632,0.00002260442,0.000019803609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005614715,0.0008181351,0.0005091228,0.00076225575,0.0001470322,0.00054700725,0.0003804697,0.00068415765,0.0011326936],"category_scores_gemma":[0.00015219155,0.0001541795,0.00042862236,0.00035142305,0.0003209567,0.0005727649,0.0002364625,0.0010373741,0.00029551866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016714385,0.00019874074,0.0003380468,0.0004385346,0.000020929967,0.00017534928,0.000064129374,0.0006431688,0.9392713,0.002774307,0.00071541686,0.055193026],"study_design_scores_gemma":[0.00007884875,0.0024767295,0.0038378467,0.00009061754,0.00010500787,0.0013111453,0.000063587926,0.004145752,0.94121915,0.001431174,0.04521258,0.00002757613],"about_ca_topic_score_codex":0.0012587401,"about_ca_topic_score_gemma":0.0017131746,"teacher_disagreement_score":0.0012587401,"about_ca_system_score_codex":0.00066385703,"about_ca_system_score_gemma":0.0005257379,"threshold_uncertainty_score":0.0048166513},"labels":[],"label_agreement":null},{"id":"W2945416434","doi":"10.1016/j.omto.2019.05.001","title":"An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In Vivo","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Oncolytic virus; In vivo; Cancer research; Oncolytic adenovirus; Virotherapy; Viral vector; Biology; Cancer; Cell; Cell growth; Cancer cell; Lung cancer; Medicine; Tumor cells; Pathology; Gene","score_opus":0.014921422829136525,"score_gpt":0.2870929348740132,"score_spread":0.2721715120448767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945416434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896075,0.0009322767,0.007752261,0.000054289856,0.0000244031,0.000070567665,0.00035036527,0.000118379736,0.001089903],"genre_scores_gemma":[0.9881511,0.00083731295,0.007022948,0.000021169952,0.0000055209107,0.00007135462,0.0006876467,0.000034800476,0.003168171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985766,0.00002233636,0.00001594415,0.00003270582,0.00004174681,0.000029544288],"domain_scores_gemma":[0.9998795,0.00002735171,0.000032455882,0.0000185048,0.000015215421,0.000026972435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023071845,0.000510756,0.00027898583,0.00034228872,0.000120711426,0.00021003783,0.00018697785,0.00026557266,0.0006434114],"category_scores_gemma":[0.000119122706,0.00016709528,0.00025241068,0.00015960528,0.00024016634,0.00018394289,0.00016908236,0.0005246406,0.00021042008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004235185,0.000020026308,0.00005829625,0.000009030706,0.0000024285516,0.000009850579,0.000005129397,0.000046012756,0.99929225,0.00005949084,0.00001314401,0.00044196268],"study_design_scores_gemma":[0.000013688813,0.00043171662,0.00086779485,0.0000018447569,0.00000701158,0.000090541536,0.0000053962904,0.00076534256,0.99709284,0.00001711105,0.00070466596,0.0000019685485],"about_ca_topic_score_codex":0.0011451833,"about_ca_topic_score_gemma":0.00095592457,"teacher_disagreement_score":0.0011451833,"about_ca_system_score_codex":0.0003614074,"about_ca_system_score_gemma":0.00037170335,"threshold_uncertainty_score":0.0026222467},"labels":[],"label_agreement":null},{"id":"W2945607155","doi":"10.1016/j.omto.2019.05.004","title":"Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; University of Ottawa","funders":"U.S. Food and Drug Administration; Government of Canada","keywords":"Medicine; Preclinical research; Oncolytic virus; Blinding; Inclusion and exclusion criteria; MEDLINE; Preclinical testing; Medical physics; Clinical study design; Clinical trial; Oncology; Pathology; Internal medicine; Alternative medicine; Cancer; Biology","score_opus":0.16571990755137075,"score_gpt":0.4718332725758467,"score_spread":0.30611336502447595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945607155","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13830028,0.35612777,0.15317897,0.03691696,0.011205289,0.17165364,0.078025416,0.0015804563,0.05301122],"genre_scores_gemma":[0.4602642,0.0756337,0.12271481,0.016718369,0.0030149287,0.27721277,0.036724355,0.0011458574,0.0065710344],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.41409284,0.18155183,0.33640677,0.009068404,0.055700287,0.0031799653],"domain_scores_gemma":[0.12906218,0.512447,0.14766222,0.055613838,0.1527186,0.0024961466],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.48614404,0.001474204,0.0050973776,0.01867463,0.0025314556,0.007381901,0.0037488046,0.003607934,0.007164702],"category_scores_gemma":[0.731097,0.0017117074,0.0060199196,0.0127233835,0.004330482,0.0061111827,0.006427804,0.0022238914,0.0018510963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008461433,0.0005079499,0.08450926,0.42420882,0.012332459,0.0019200236,0.025425972,0.0020214787,0.006968531,0.016629813,0.062158067,0.35485622],"study_design_scores_gemma":[0.0021141723,0.002244123,0.072115295,0.31092048,0.017034365,0.0023349933,0.00648802,0.0026479024,0.015831752,0.01849217,0.54920995,0.000566762],"about_ca_topic_score_codex":0.0024074272,"about_ca_topic_score_gemma":0.0029735577,"teacher_disagreement_score":0.51385593,"about_ca_system_score_codex":0.0064174975,"about_ca_system_score_gemma":0.019790486,"threshold_uncertainty_score":0.6336759},"labels":[],"label_agreement":null},{"id":"W2955578428","doi":"10.1016/j.omto.2019.06.004","title":"Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Ontario Institute for Cancer Research; Francis Crick Institute","keywords":"Oncolytic virus; Vaccinia; Virus; Virology; Thymidine kinase; Biology; Apoptosis; Cancer; Viral replication; Cancer research; Programmed cell death; Cancer cell; Suicide gene; Genetic enhancement; Gene; Genetics; Herpes simplex virus","score_opus":0.014554761161068729,"score_gpt":0.3083931455120693,"score_spread":0.29383838435100057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955578428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125963,0.001908104,0.005370288,0.000116518764,0.000035132794,0.000036420934,0.0002813996,0.00011410153,0.00087847153],"genre_scores_gemma":[0.99299604,0.00080816617,0.0042026085,0.00003783078,0.000010729909,0.000030360716,0.00049328647,0.00003238527,0.0013884901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981827,0.000026794118,0.000024020223,0.000038397095,0.00004842898,0.000044050452],"domain_scores_gemma":[0.9998642,0.00003119439,0.000053223954,0.000016225287,0.000014177355,0.000020876498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014488117,0.0003843146,0.00035502715,0.00024258438,0.00013095223,0.00035130946,0.0002296722,0.00045001454,0.0008284612],"category_scores_gemma":[0.00017086465,0.00013960518,0.00034674662,0.00012860683,0.00022116613,0.00026140432,0.00018677348,0.00060648366,0.00033227814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006791256,0.000026086642,0.00015392859,0.000023405511,0.0000034134723,0.000022298365,0.000007823164,0.0001015751,0.9982711,0.00007728996,0.00002062836,0.0012243389],"study_design_scores_gemma":[0.000015864938,0.00024745215,0.0011789266,0.000006085595,0.000016212722,0.000205512,0.0000072928246,0.0009275797,0.9950896,0.00002992648,0.0022706282,0.000004879227],"about_ca_topic_score_codex":0.00042413315,"about_ca_topic_score_gemma":0.00033698525,"teacher_disagreement_score":0.0008284612,"about_ca_system_score_codex":0.00035476885,"about_ca_system_score_gemma":0.00023499483,"threshold_uncertainty_score":0.0027714968},"labels":[],"label_agreement":null},{"id":"W2963978412","doi":"10.1016/j.omto.2019.07.003","title":"Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; St. Paul's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Michael Smith Health Research BC; Terry Fox Research Institute; University of British Columbia; Canadian Lung Association; BC Cancer Foundation; Vancouver Coastal Health Research Institute; British Columbia Lung Association; Canadian Institutes of Health Research; Mitacs; International Association for the Study of Lung Cancer","keywords":"Oncolytic virus; KRAS; Virology; Adenocarcinoma; Coxsackievirus; Mutant; Cancer research; Virus; Biology; Mutation; Medicine; Enterovirus; Internal medicine; Cancer; Genetics; Gene","score_opus":0.01715183600050761,"score_gpt":0.29643740505648053,"score_spread":0.2792855690559729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963978412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96288466,0.012822382,0.011491749,0.00087295694,0.00031679226,0.0002547122,0.0013681126,0.00029082166,0.009697727],"genre_scores_gemma":[0.9835306,0.0045834957,0.0054870234,0.00012128705,0.000028976638,0.00006853614,0.0014979981,0.000038830494,0.004643322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990606,0.000020824558,0.000005675705,0.0000114112545,0.00003102599,0.000024993426],"domain_scores_gemma":[0.9999223,0.000016429494,0.000015908014,0.000008104951,0.000009931947,0.00002744915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022192259,0.00024178544,0.00016654714,0.0002651117,0.00021803178,0.000284958,0.0001588151,0.0003152583,0.0010681582],"category_scores_gemma":[0.00014305592,0.000115906856,0.00020327438,0.00027557454,0.0002512965,0.00018543673,0.0001680463,0.0007959347,0.0004026539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032491575,0.00006588593,0.00027955289,0.00006687467,0.000009389438,0.000059112674,0.000015885367,0.00011734497,0.99274206,0.00058335415,0.00043003887,0.0053055687],"study_design_scores_gemma":[0.00018203896,0.002157894,0.0063555236,0.000021914126,0.00003218438,0.0011247614,0.000040486426,0.001331489,0.96199447,0.0003101768,0.026436169,0.000012888082],"about_ca_topic_score_codex":0.0026189412,"about_ca_topic_score_gemma":0.002891339,"teacher_disagreement_score":0.0026189412,"about_ca_system_score_codex":0.00039529055,"about_ca_system_score_gemma":0.00047788207,"threshold_uncertainty_score":0.0052074194},"labels":[],"label_agreement":null},{"id":"W2970333537","doi":"10.1016/j.omto.2019.08.003","title":"Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Yamaguchi University; University of Michigan","keywords":"Oncolytic virus; Cancer research; Combination therapy; Melanoma; Virotherapy; Cell culture; Cancer; Virology; Biology; Medicine; Virus; Pharmacology; Internal medicine","score_opus":0.012122621008826724,"score_gpt":0.2768667207527858,"score_spread":0.26474409974395907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970333537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960454,0.0017935031,0.00080688164,0.00003948761,0.000018702074,0.000038281174,0.00010091327,0.00002999539,0.0011267952],"genre_scores_gemma":[0.9962243,0.0010912182,0.0012071903,0.000017200007,0.0000062697436,0.000018951301,0.00019853059,0.0000073108527,0.0012290938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999149,0.000014910106,0.000005959542,0.000017109214,0.00002343484,0.000023627317],"domain_scores_gemma":[0.9999676,0.0000059499744,0.000008052711,0.000003657306,0.000004011888,0.00001060012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011703836,0.0002818631,0.00035929622,0.0003420325,0.00010706893,0.0002532107,0.00018648324,0.00018751113,0.0008266604],"category_scores_gemma":[0.00007339581,0.00009493544,0.00023569044,0.00013295177,0.000108588836,0.00020491035,0.00015488073,0.0003897151,0.00015410967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027519366,0.00013650554,0.00027932186,0.00006164151,0.000011992048,0.00004746074,0.000018737202,0.00031076765,0.9942836,0.00007049214,0.0000637059,0.004440602],"study_design_scores_gemma":[0.000039703427,0.0030433123,0.002707487,0.0000058273745,0.000042426986,0.00027277216,0.000019533347,0.0010867042,0.98959863,0.000029188908,0.003147713,0.000006535493],"about_ca_topic_score_codex":0.0006853522,"about_ca_topic_score_gemma":0.002074106,"teacher_disagreement_score":0.0008266604,"about_ca_system_score_codex":0.00023494892,"about_ca_system_score_gemma":0.00017414238,"threshold_uncertainty_score":0.002765417},"labels":[],"label_agreement":null},{"id":"W3002247662","doi":"10.1016/j.omto.2020.01.002","title":"MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Occupational Cancer Research Centre; St. Paul's Hospital; University of British Columbia","funders":"Providence Health Care Research Institute; Canadian Institutes of Health Research; BC Cancer Foundation; British Columbia Lung Association; Vancouver Coastal Health Research Institute; University of British Columbia; Michael Smith Health Research BC; Terry Fox Research Institute","keywords":"Oncolytic virus; KRAS; Adenocarcinoma; Cancer research; Coxsackievirus; Toxicity; Lung cancer; Cancer; Mutant; Cytotoxicity; Biology; Virus; In vitro; Medicine; Virology; Pathology; Gene; Internal medicine; Colorectal cancer","score_opus":0.050242848173631026,"score_gpt":0.33918163930300593,"score_spread":0.28893879112937493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002247662","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29181564,0.2008777,0.057977233,0.051434286,0.34851888,0.00027280964,0.005183695,0.006148697,0.03777114],"genre_scores_gemma":[0.769459,0.102161236,0.0270077,0.014565989,0.013649225,0.0002323507,0.003198363,0.0019809755,0.067745216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955136,0.000048751877,0.000049301623,0.00007132973,0.00019681174,0.00008231341],"domain_scores_gemma":[0.99976164,0.000074593365,0.00006598807,0.000025886313,0.000040303436,0.000031609103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006196048,0.0011069672,0.0011995004,0.00029329647,0.00042759965,0.001113261,0.0009809728,0.0016019546,0.0069517605],"category_scores_gemma":[0.0010668656,0.00047870408,0.00064908114,0.00037399703,0.00061887736,0.00065147836,0.0003650664,0.0019359869,0.0021753563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090139883,0.00014349927,0.0005736994,0.0018975543,0.00019771027,0.0015756052,0.00012850955,0.0011878742,0.7636338,0.0096533215,0.122902855,0.09720418],"study_design_scores_gemma":[0.0001755079,0.00074579654,0.0035887037,0.00011657511,0.0002766849,0.004957174,0.00011719645,0.0030004533,0.5654273,0.0011682982,0.42030737,0.00011896723],"about_ca_topic_score_codex":0.0013285715,"about_ca_topic_score_gemma":0.002777971,"teacher_disagreement_score":0.0069517605,"about_ca_system_score_codex":0.0007184774,"about_ca_system_score_gemma":0.00077126164,"threshold_uncertainty_score":0.023255944},"labels":[],"label_agreement":null},{"id":"W3016228284","doi":"10.1016/j.omto.2020.03.018","title":"Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Ben and Catherine Ivy Foundation; Canary Foundation","keywords":"Chimeric antigen receptor; Oncolytic virus; Antigen; CD19; Cancer research; Cell therapy; Melanoma; Cell; Biology; Immunotherapy; Immunology; Virology; Immune system; Tumor cells","score_opus":0.01980434138450807,"score_gpt":0.3008079975698722,"score_spread":0.2810036561853641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016228284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550328,0.0045764777,0.03208218,0.00045818053,0.00017173775,0.00021845721,0.00040851888,0.0005591128,0.006492568],"genre_scores_gemma":[0.98617005,0.0011828769,0.008144386,0.000048420374,0.000023895282,0.000051796353,0.0001951799,0.000059241982,0.0041242563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976796,0.000043038777,0.000012667346,0.000047374004,0.00006599131,0.00006294834],"domain_scores_gemma":[0.9998865,0.000029859617,0.000023452265,0.000019034524,0.000010218885,0.00003079436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002141365,0.00043756687,0.00029691745,0.00036703298,0.00021633376,0.0006809498,0.00020991491,0.00045937972,0.001801882],"category_scores_gemma":[0.00016864167,0.0001651851,0.00021752826,0.00019803536,0.00040057307,0.0002934895,0.0002673997,0.00077025243,0.0005801224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006424227,0.00008414888,0.00013836478,0.00006006713,0.000011631459,0.00007577926,0.000028519873,0.0002882796,0.99173003,0.0013274001,0.00018546602,0.0060061635],"study_design_scores_gemma":[0.000025056053,0.00047419674,0.000355051,0.000004921245,0.000016947259,0.00022967054,0.0000117858335,0.0016896861,0.99097496,0.000081959675,0.006131827,0.000003999341],"about_ca_topic_score_codex":0.0010570674,"about_ca_topic_score_gemma":0.001917355,"teacher_disagreement_score":0.001801882,"about_ca_system_score_codex":0.000496522,"about_ca_system_score_gemma":0.00044229897,"threshold_uncertainty_score":0.0060278773},"labels":[],"label_agreement":null},{"id":"W3016877653","doi":"10.1016/j.omto.2020.04.001","title":"A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Cancer Society","keywords":"CD28; Chimeric antigen receptor; T cell; Peripheral blood mononuclear cell; Toxicity; CD8; Cytokine release syndrome; Cytotoxic T cell; Adoptive cell transfer; Cancer research; Cytokine; T-cell receptor; Cell; Immunology; Medicine; Antigen; Pharmacology; Biology; Chemistry; Immune system; Internal medicine; In vitro; Biochemistry","score_opus":0.05817557353079079,"score_gpt":0.3426282375479575,"score_spread":0.28445266401716673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016877653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624368,0.0019218817,0.03217401,0.00014671613,0.00005011498,0.000085092994,0.0001415153,0.000084402614,0.0029594444],"genre_scores_gemma":[0.9932827,0.00047715084,0.0046352334,0.000065053275,0.0000074528584,0.00003168763,0.00017142981,0.000012208329,0.0013170412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999144,0.000027786056,0.0000041228823,0.0000200166,0.000018671602,0.000014934234],"domain_scores_gemma":[0.99989974,0.000039845618,0.000019902669,0.000014160778,0.00001104968,0.000015270096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021024341,0.00033441978,0.00019590526,0.00013875066,0.00015229217,0.00021804344,0.00031763926,0.00038859088,0.0012497951],"category_scores_gemma":[0.00015301793,0.00008150977,0.00024509217,0.00008792825,0.00033445135,0.00030761576,0.00014003155,0.00064950105,0.00019757176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008731257,0.00008425548,0.0003005906,0.000035584744,0.00001069245,0.00011043766,0.00001013444,0.0007848268,0.9953928,0.0017174429,0.000042442185,0.0014235494],"study_design_scores_gemma":[0.000017396515,0.00072239945,0.0010699978,0.0000054696775,0.00002069851,0.00041262497,0.000015953057,0.006844026,0.98782504,0.0005948329,0.0024661142,0.000005435104],"about_ca_topic_score_codex":0.0005509279,"about_ca_topic_score_gemma":0.00042758454,"teacher_disagreement_score":0.0012497951,"about_ca_system_score_codex":0.0004973967,"about_ca_system_score_gemma":0.00023342678,"threshold_uncertainty_score":0.004180968},"labels":[],"label_agreement":null},{"id":"W3046293265","doi":"10.1016/j.omto.2020.07.008","title":"Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Biotechnology and Biological Sciences Research Council; University of Bristol; Engineering and Physical Sciences Research Council; University of Bath; Canolfan Ymchwil Canser Cymru; Cancer Research UK; Wellcome Trust","keywords":"Underpinning; Receptor; Immunotherapy; Cell biology; Chemistry; Cell; Computational biology; Biology; Biochemistry; Immunology; Immune system; Engineering","score_opus":0.04400329613346489,"score_gpt":0.32832955590108875,"score_spread":0.2843262597676239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046293265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983196,0.00043410636,0.012446196,0.00011029706,0.000016169326,0.000025410765,0.000053576794,0.00006626788,0.0036519167],"genre_scores_gemma":[0.99690163,0.00026833554,0.002324812,0.000033529806,0.0000026008217,0.00001584567,0.000042982763,0.000012511119,0.00039779392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987555,0.000019372397,0.0000073657416,0.000022202792,0.000041673215,0.000033733966],"domain_scores_gemma":[0.9999398,0.000023864282,0.000015210245,0.000004136468,0.0000074372047,0.000009588755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015994074,0.00023017774,0.00022027215,0.00012887483,0.0002742823,0.00050376134,0.00031815813,0.00036561303,0.0013612754],"category_scores_gemma":[0.00034999673,0.00024320224,0.00015682884,0.00008063824,0.00045169605,0.0004693692,0.0002510702,0.00057562994,0.00024410337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020583264,0.00010367845,0.0015318124,0.00011296794,0.000027004773,0.00049489306,0.00008963539,0.050088264,0.9193168,0.023819579,0.00034975566,0.0038597614],"study_design_scores_gemma":[0.00017023065,0.0003411407,0.005560568,0.000027520377,0.000057219055,0.0008326781,0.00029748946,0.36137912,0.6087361,0.01636199,0.0061711716,0.000064813205],"about_ca_topic_score_codex":0.0006865675,"about_ca_topic_score_gemma":0.0011156028,"teacher_disagreement_score":0.0013612754,"about_ca_system_score_codex":0.00041058546,"about_ca_system_score_gemma":0.00032751405,"threshold_uncertainty_score":0.004553914},"labels":[],"label_agreement":null},{"id":"W3090311836","doi":"10.1016/j.omto.2020.09.010","title":"Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Rosetrees Trust; Prostate Cancer UK; National Institute for Health and Care Research; Cancer Research UK","keywords":"Oncolytic virus; Innate immune system; Immunotherapy; Immune system; Cancer research; Immunology; Medicine; Prostate cancer; Biology; Internal medicine; Cancer","score_opus":0.04403722444281576,"score_gpt":0.3218439555676428,"score_spread":0.277806731124827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090311836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549747,0.0013966244,0.0015700484,0.00007753118,0.00004351976,0.00003625706,0.00015431126,0.00013469694,0.0010895599],"genre_scores_gemma":[0.9967429,0.000535966,0.00083321927,0.000025565776,0.000009701121,0.000020903166,0.00020507144,0.000015941221,0.0016107867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999045,0.0000122330985,0.000006070301,0.000017425946,0.00002223785,0.0000374967],"domain_scores_gemma":[0.9999393,0.000011776011,0.000014782532,0.0000093229155,0.0000058401492,0.000018966055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092414,0.00029032826,0.00024080423,0.00016981427,0.0000751914,0.00026848132,0.000174852,0.00018156189,0.0009529115],"category_scores_gemma":[0.00007014756,0.00011200776,0.0002037902,0.00008791668,0.00012875065,0.00016716142,0.00012449372,0.00091647654,0.00018885093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015610682,0.00008995797,0.00007285949,0.000031747677,0.000005519808,0.000012906921,0.000009211906,0.00012231004,0.9966324,0.000082227765,0.000062877545,0.0027219516],"study_design_scores_gemma":[0.000044259763,0.0015212453,0.0020196112,0.000005857455,0.000021254444,0.0001548678,0.000019130195,0.0012629735,0.99264294,0.000041737072,0.002261398,0.000004671284],"about_ca_topic_score_codex":0.0004797559,"about_ca_topic_score_gemma":0.0008415715,"teacher_disagreement_score":0.0009529115,"about_ca_system_score_codex":0.00021481626,"about_ca_system_score_gemma":0.00022170263,"threshold_uncertainty_score":0.0031877756},"labels":[],"label_agreement":null},{"id":"W3093325782","doi":"10.1016/j.omto.2020.10.007","title":"Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Mitacs; Terry Fox Research Institute; Canadian Cancer Society; McMaster University","keywords":"Oncolytic virus; Priming (agriculture); Immunotherapy; Virology; Biology; Cancer vaccine; Cancer immunotherapy; Medicine; Immunology; Immune system; Virus","score_opus":0.02298976060557455,"score_gpt":0.33258152679928465,"score_spread":0.3095917661937101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093325782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97436476,0.003532083,0.017003182,0.00023806989,0.00016634815,0.00026230133,0.00022168853,0.00029872276,0.0039129606],"genre_scores_gemma":[0.98697263,0.0011362513,0.008936622,0.00007579159,0.000018562852,0.0000564351,0.00012838733,0.000019604688,0.002655609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999405,0.000008900861,0.000003072613,0.0000128198435,0.000014469723,0.000020247382],"domain_scores_gemma":[0.99996376,0.000009440358,0.000008328933,0.000003855385,0.000004137297,0.0000104117735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011807876,0.0002841051,0.00023344703,0.00012886389,0.00008786413,0.00020674276,0.00012544345,0.00028226757,0.0015815264],"category_scores_gemma":[0.00008308176,0.00012274842,0.00016021091,0.00006638012,0.0001376843,0.00018563382,0.00014204558,0.0005918259,0.00034917117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016772379,0.00011813893,0.00008148232,0.00005374995,0.00000333404,0.000031985408,0.00001007889,0.0003867451,0.9948639,0.00027771614,0.0001003875,0.0039047953],"study_design_scores_gemma":[0.0000555356,0.0012999038,0.0008793748,0.000008183825,0.00001638573,0.00028573093,0.000011446143,0.002803205,0.9902559,0.00015292774,0.004226441,0.00000499808],"about_ca_topic_score_codex":0.0003268889,"about_ca_topic_score_gemma":0.0006629548,"teacher_disagreement_score":0.0015815264,"about_ca_system_score_codex":0.0002453159,"about_ca_system_score_gemma":0.0003538997,"threshold_uncertainty_score":0.005290687},"labels":[],"label_agreement":null},{"id":"W3123083777","doi":"10.1016/j.omto.2021.01.007","title":"A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Robarts Clinical Trials; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Western University; Prostate Cancer Canada","keywords":"Minicircle; Survivin; Prostate cancer; Cancer research; Cytosine deaminase; Cancer; Biology; Reporter gene; Suicide gene; Medicine; Molecular biology; Genetic enhancement; Gene; Gene expression; Biochemistry; Genetics","score_opus":0.016905137106802977,"score_gpt":0.2800677928765921,"score_spread":0.26316265576978914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123083777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5306166,0.018882243,0.436657,0.00092557346,0.00067622506,0.0013079457,0.0019758358,0.003431758,0.005526786],"genre_scores_gemma":[0.8238904,0.007620171,0.15208471,0.00049150374,0.00013956253,0.00061328855,0.004448401,0.00021493723,0.01049707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963164,0.00005851197,0.000033575066,0.00011645843,0.000117096344,0.00004263097],"domain_scores_gemma":[0.9997626,0.000031371077,0.00008551241,0.000029384242,0.000044892062,0.000046118348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003245825,0.00057500944,0.00038168085,0.00041489772,0.00021382578,0.00041410292,0.0004369885,0.0005682297,0.00081446907],"category_scores_gemma":[0.00040407758,0.00030002368,0.00035977538,0.00026092623,0.00030085578,0.00037915012,0.00028954571,0.0009908925,0.0006795443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004811534,0.000023789175,0.000085623506,0.00008400624,0.0000067731216,0.000032114174,0.0000215141,0.00010675282,0.9933137,0.00043560634,0.00020154298,0.005640464],"study_design_scores_gemma":[0.000014853775,0.00041924499,0.0005474142,0.000008285461,0.000030744846,0.00046009498,0.000006872702,0.0010325874,0.985443,0.000049344202,0.011972789,0.000014814389],"about_ca_topic_score_codex":0.00035649093,"about_ca_topic_score_gemma":0.00043459426,"teacher_disagreement_score":0.00081446907,"about_ca_system_score_codex":0.00041962593,"about_ca_system_score_gemma":0.00042089284,"threshold_uncertainty_score":0.0030446649},"labels":[],"label_agreement":null},{"id":"W3125433041","doi":"10.1016/j.omto.2021.01.009","title":"Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Hospital; University of Ottawa; University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Veterinary College, University of Guelph; Cancer Research Society","keywords":"Oncolytic virus; Cancer research; Innate immune system; Tumor microenvironment; Immune system; Interferon; Immunology; Cancer; Newcastle disease; Monocyte; Immunotherapy; Biology; Virus; Medicine; Internal medicine","score_opus":0.019897762554918062,"score_gpt":0.29464746754851884,"score_spread":0.2747497049936008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125433041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991235,0.0015408702,0.004444835,0.00014554527,0.000085426145,0.000099704936,0.00018796453,0.00019537764,0.002065308],"genre_scores_gemma":[0.9938791,0.00076798775,0.0023565127,0.00002558541,0.00002352372,0.000045781584,0.00020401941,0.000023998393,0.0026734138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997881,0.000041629373,0.0000183543,0.000028652626,0.00005541092,0.00006786654],"domain_scores_gemma":[0.9998534,0.00003202905,0.000038578666,0.000022021664,0.000011883512,0.000041983392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027504718,0.000496358,0.0004330509,0.00039851782,0.00013173475,0.00033275684,0.00031046485,0.00028824265,0.0009232092],"category_scores_gemma":[0.0001412922,0.00018402516,0.00034914407,0.00014009779,0.000361036,0.00025962468,0.0002510417,0.0008407548,0.00020714567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002792252,0.00013855672,0.00008837541,0.00003827774,0.000011761539,0.000024302288,0.00001963882,0.00028011575,0.9971059,0.00016391824,0.000043496806,0.0018064457],"study_design_scores_gemma":[0.000038593793,0.0024929198,0.0006223981,0.0000044706117,0.000021025808,0.00007268879,0.000011199079,0.0007001939,0.99459237,0.000044222354,0.0013951205,0.0000047370436],"about_ca_topic_score_codex":0.0010067194,"about_ca_topic_score_gemma":0.0020273842,"teacher_disagreement_score":0.0010067194,"about_ca_system_score_codex":0.00031663667,"about_ca_system_score_gemma":0.00034548843,"threshold_uncertainty_score":0.0030884743},"labels":[],"label_agreement":null},{"id":"W3129515331","doi":"10.1016/j.omto.2021.02.009","title":"Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Winship Cancer Institute; National Cancer Institute; National Institutes of Health; Genentech; AstraZeneca; Oncolytics Biotech; Minneapolis Medical Research Foundation; Bristol-Myers Squibb; GlaxoSmithKline; Multiple Myeloma Research Foundation; American Cancer Society","keywords":"Oncolytic virus; Herpes simplex virus; Tropism; Virus; Biology; Virology; Viral replication; Cell culture; Cancer cell; Cancer research; Cancer","score_opus":0.014863387662776239,"score_gpt":0.2949697748991098,"score_spread":0.2801063872363336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129515331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350938,0.021073626,0.029888047,0.0005286457,0.00032840483,0.00019681237,0.0030055156,0.0004041294,0.009480965],"genre_scores_gemma":[0.96930176,0.009314853,0.011353307,0.0002067372,0.00006668706,0.00011486232,0.0023548696,0.00005442404,0.0072324476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995952,0.00007991323,0.0000371189,0.00007151036,0.00013495969,0.000081194295],"domain_scores_gemma":[0.9998111,0.00006801363,0.000031727097,0.00003640507,0.000027378806,0.000025355039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037970548,0.00040324006,0.0003184176,0.00027165143,0.00019886318,0.00051175157,0.00021390039,0.0003364349,0.0013716121],"category_scores_gemma":[0.0002632298,0.00018931535,0.00027945728,0.0002503452,0.00016295984,0.0002756962,0.00025567567,0.0007904115,0.000706168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014311918,0.00007872355,0.00085928274,0.00011897085,0.00002248421,0.000045877718,0.00006543431,0.0002349787,0.9910931,0.00032659608,0.00036754415,0.0066439887],"study_design_scores_gemma":[0.00003169954,0.0009887061,0.0063657267,0.000021718917,0.000032502314,0.00035860678,0.00007048092,0.0021836981,0.9786391,0.00030562188,0.010991167,0.000010930044],"about_ca_topic_score_codex":0.0022729523,"about_ca_topic_score_gemma":0.0022671754,"teacher_disagreement_score":0.0022729523,"about_ca_system_score_codex":0.00046480793,"about_ca_system_score_gemma":0.0003317872,"threshold_uncertainty_score":0.0045885444},"labels":[],"label_agreement":null},{"id":"W3155151917","doi":"10.1016/j.omto.2021.04.002","title":"Angiogenesis-related non-coding RNAs and gastrointestinal cancer","year":2021,"lang":"en","type":"review","venue":"Molecular Therapy — Oncolytics","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Merck KGaA","keywords":"Angiogenesis; Gastrointestinal cancer; Coding (social sciences); Computational biology; Cancer research; Cancer; Biology; Medicine; Colorectal cancer; Genetics; Mathematics","score_opus":0.03504720043554781,"score_gpt":0.36022704629734364,"score_spread":0.3251798458617958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155151917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108337175,0.99772733,0.00011989659,0.00027991342,0.00027637518,0.000004284536,0.000015713458,0.000009408382,0.0014586754],"genre_scores_gemma":[0.0005853682,0.998139,0.000121570774,0.00019997027,0.0001387225,0.0000049481646,0.000029377903,0.0000012107013,0.0007797562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989915,0.000015276408,0.000010926119,0.000016926866,0.00004506489,0.000012573775],"domain_scores_gemma":[0.99986815,0.000053908898,0.000018451634,0.0000035435112,0.000038940078,0.000016894992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024854956,0.00059264695,0.0007675209,0.00127289,0.00023371296,0.0006587499,0.00049475435,0.0007757277,0.0037406494],"category_scores_gemma":[0.0003610945,0.00018583094,0.00030108474,0.0013233483,0.00030871222,0.0009296312,0.00043898425,0.001519577,0.0020676395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063070824,0.00005967628,0.0001253929,0.01285905,0.00005625117,0.00020636152,0.000049073296,0.000353381,0.0033134508,0.005097009,0.046264928,0.9315524],"study_design_scores_gemma":[0.00001044388,0.00007067199,0.00051358825,0.001615115,0.000041360825,0.0009876626,0.000027508742,0.0000566906,0.00041603326,0.0018024037,0.9944484,0.000010236721],"about_ca_topic_score_codex":0.00073827343,"about_ca_topic_score_gemma":0.0013504191,"teacher_disagreement_score":0.0037406494,"about_ca_system_score_codex":0.000571071,"about_ca_system_score_gemma":0.00090436783,"threshold_uncertainty_score":0.012513697},"labels":[],"label_agreement":null},{"id":"W3158023608","doi":"10.1016/j.omto.2021.04.015","title":"MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Medizinischen Fakultät Heidelberg, Universität Heidelberg; Helmholtz Association; Deutsche Krebshilfe; Universität Heidelberg; Deutsches Krebsforschungszentrum","keywords":"Oncolytic virus; Pancreatic cancer; Cancer research; Virotherapy; Measles virus; Cytosine deaminase; Medicine; Prodrug; Cancer; Genetic enhancement; Virology; Pharmacology; Biology; Internal medicine; Vaccination; Measles","score_opus":0.026345778887391702,"score_gpt":0.32879804360283643,"score_spread":0.30245226471544473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158023608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95754355,0.0057067866,0.033859793,0.00024001324,0.00007243504,0.00018271837,0.00016267,0.00015340248,0.002078486],"genre_scores_gemma":[0.98148924,0.0017037791,0.0154895075,0.000041352567,0.000010739658,0.000058893133,0.00015066925,0.000018579341,0.0010371727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986696,0.000037938393,0.000010134368,0.000026173284,0.000039191997,0.00001960427],"domain_scores_gemma":[0.9999603,0.0000072519256,0.000011573909,0.0000071078503,0.000004702422,0.000009130612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022447009,0.00020797094,0.00018668675,0.0001623401,0.00013355061,0.00024713058,0.0001803572,0.0002404092,0.00035609133],"category_scores_gemma":[0.00014628434,0.00011655634,0.00020167338,0.00012293326,0.00019571296,0.0001747425,0.00017705467,0.00046362224,0.00013047573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045536744,0.000022845355,0.0001222681,0.000029773806,0.000005473032,0.000024355588,0.00001384732,0.00020114797,0.9959287,0.0004273781,0.000038384896,0.0031402244],"study_design_scores_gemma":[0.000012939512,0.00031717506,0.00049335253,0.0000051311918,0.000014770709,0.00028021503,0.000006161953,0.0014649286,0.9938917,0.00006284221,0.0034461431,0.000004560583],"about_ca_topic_score_codex":0.00039346717,"about_ca_topic_score_gemma":0.0005801708,"teacher_disagreement_score":0.00042528458,"about_ca_system_score_codex":0.00042528458,"about_ca_system_score_gemma":0.00033990675,"threshold_uncertainty_score":0.0030856133},"labels":[],"label_agreement":null},{"id":"W3163408869","doi":"10.1016/j.omto.2021.05.007","title":"Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Children's Hospital of Eastern Ontario; University Health Network","funders":"Canadian Cancer Society Research Institute","keywords":"Oncolytic virus; Vaccinia; Biology; Virus; Virotherapy; Immune system; Cancer research; Interferon; Gene; Virology; Mutant; Immunology; Genetics","score_opus":0.025663920561004316,"score_gpt":0.3008025625386601,"score_spread":0.2751386419776558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163408869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93749,0.0036135386,0.055690404,0.00024589783,0.00008971973,0.00011644283,0.00023804615,0.00014864915,0.0023672292],"genre_scores_gemma":[0.95440096,0.0031090039,0.039835338,0.000073002535,0.000026652344,0.00009534492,0.0003654402,0.000040828774,0.0020533444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984753,0.0000375288,0.000016319102,0.00003138314,0.000045396508,0.000021757463],"domain_scores_gemma":[0.99993205,0.000011705352,0.00002580696,0.00001239997,0.0000076233955,0.000010518288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022375063,0.00044985887,0.00027585396,0.00020491818,0.00014869195,0.0004094841,0.0003039255,0.00029388067,0.00037028774],"category_scores_gemma":[0.00011040854,0.00014987784,0.0002555906,0.00012369534,0.00029116956,0.0002463815,0.0002816286,0.0007113571,0.00025877653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003419234,0.00001876087,0.00009294309,0.000024612744,0.0000023479831,0.000022396784,0.000009187476,0.0001864016,0.99721575,0.0005067547,0.000017456145,0.0018691393],"study_design_scores_gemma":[0.00001052035,0.00017633813,0.00032205367,0.0000042053975,0.000009110059,0.00019594611,0.0000056877007,0.0009035997,0.9930825,0.000078863886,0.0052067726,0.0000043378245],"about_ca_topic_score_codex":0.0001698575,"about_ca_topic_score_gemma":0.0001596444,"teacher_disagreement_score":0.00044985887,"about_ca_system_score_codex":0.0003264638,"about_ca_system_score_gemma":0.0002228885,"threshold_uncertainty_score":0.0023686886},"labels":[],"label_agreement":null},{"id":"W4200118074","doi":"10.1016/j.omto.2021.12.016","title":"Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockade","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Kanae Foundation for the Promotion of Medical Science; National Institutes of Health; Neuroendocrine Tumor Research Foundation; Ottawa Hospital Research Institute","keywords":"Oncolytic virus; Neuroendocrine tumors; Vaccinia; Cancer research; Virus; Apoptosis; CD8; Biology; Immune system; Immunology; Medicine; Internal medicine","score_opus":0.013508484088663994,"score_gpt":0.28379881088495107,"score_spread":0.27029032679628706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200118074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851924,0.0004320793,0.0005114619,0.000022224924,0.000019611816,0.000021029775,0.00004808767,0.000023834971,0.0004022959],"genre_scores_gemma":[0.9980453,0.00037582582,0.00055476464,0.000017872917,0.0000105554755,0.000027328422,0.00011792774,0.000007107179,0.00084332144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989796,0.000016972706,0.0000072923413,0.000023356533,0.000020289295,0.0000341151],"domain_scores_gemma":[0.99992967,0.000018302622,0.000017127819,0.000009458833,0.0000041410403,0.00002117847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101699545,0.00026434872,0.00028552554,0.00012215502,0.000057841356,0.00018491816,0.00012536524,0.00018208199,0.00065937015],"category_scores_gemma":[0.00009677409,0.00010371191,0.00016837766,0.00006355267,0.00015110445,0.00018533067,0.00010986054,0.0006660526,0.00011238972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024493996,0.00011799909,0.00020682425,0.000025451256,0.0000046570703,0.00003326518,0.0000116882275,0.00010464723,0.99735,0.00007205336,0.000017713566,0.001810847],"study_design_scores_gemma":[0.00008428931,0.00503598,0.004062011,0.0000052056494,0.000017451488,0.0003219531,0.00002242834,0.0013085604,0.9878368,0.000047556106,0.0012536455,0.0000042137262],"about_ca_topic_score_codex":0.00022618083,"about_ca_topic_score_gemma":0.00041011602,"teacher_disagreement_score":0.00065937015,"about_ca_system_score_codex":0.00017400875,"about_ca_system_score_gemma":0.00014589053,"threshold_uncertainty_score":0.0022058487},"labels":[],"label_agreement":null},{"id":"W4210729268","doi":"10.1016/j.omto.2022.01.009","title":"Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Bladder cancer; Oncolytic virus; Immunotherapy; Vesicular stomatitis virus; Cystectomy; Medicine; Cancer research; Cancer; Oncolytic adenovirus; Oncology; Immunology; Virus; Internal medicine","score_opus":0.016642566042290707,"score_gpt":0.30906429545067116,"score_spread":0.29242172940838046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210729268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997419,0.0015302136,0.0005524968,0.000045242818,0.000017913833,0.000016995677,0.00004239907,0.000041242758,0.00033443535],"genre_scores_gemma":[0.99844897,0.0005885426,0.0004032615,0.000015924541,0.0000056088797,0.000011154727,0.0001047038,0.000003970587,0.00041777806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99995935,0.000007851281,0.0000031192376,0.0000065439694,0.00000846846,0.000014636068],"domain_scores_gemma":[0.99996984,0.00000506351,0.000007262577,0.0000037244085,0.0000025924649,0.000011529789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098466226,0.00016947553,0.00022543849,0.00012571336,0.000064362066,0.0001880083,0.00011262218,0.0001786436,0.0002978633],"category_scores_gemma":[0.000062961204,0.00005057228,0.00011520714,0.000112901216,0.00014835419,0.00010211779,0.00010889141,0.00035301226,0.00006865057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006377555,0.00034939387,0.0009065319,0.000068748835,0.0000147078845,0.000048070877,0.000023359917,0.00043894205,0.9840486,0.00010171656,0.000115661096,0.013246454],"study_design_scores_gemma":[0.00015571795,0.010837648,0.020380327,0.000024254605,0.00007646581,0.00048779068,0.00004494992,0.0034781045,0.9613931,0.00012661748,0.0029866158,0.000008309438],"about_ca_topic_score_codex":0.00032511953,"about_ca_topic_score_gemma":0.0004176021,"teacher_disagreement_score":0.00032511953,"about_ca_system_score_codex":0.0001727026,"about_ca_system_score_gemma":0.00017264974,"threshold_uncertainty_score":0.0012530684},"labels":[],"label_agreement":null},{"id":"W4212894372","doi":"10.1016/j.omto.2022.02.017","title":"NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; University of New Brunswick; University of Prince Edward Island; Nova Scotia Health Authority; Dalhousie University","funders":"National Institute of General Medical Sciences","keywords":"Multiple myeloma; NAD+ kinase; Virology; Cancer research; Chemistry; Biology; Immunology; Biochemistry; Enzyme","score_opus":0.025562086740894593,"score_gpt":0.2910022954302799,"score_spread":0.2654402086893853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212894372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676676,0.0016808524,0.005721322,0.00017071274,0.00006576524,0.000071945535,0.00097571,0.00025091495,0.0042960094],"genre_scores_gemma":[0.9931252,0.00038072042,0.002437846,0.000041657913,0.0000058459664,0.0000323171,0.0007806402,0.000032492877,0.0031631973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988174,0.000014289454,0.000010199909,0.000021616901,0.000042470856,0.000029598892],"domain_scores_gemma":[0.9999442,0.000011348753,0.000008898772,0.00000889794,0.0000075136186,0.000019104733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011066678,0.00026467833,0.00021785308,0.0001355319,0.00010612627,0.0003530567,0.00023126045,0.00019893447,0.0023826566],"category_scores_gemma":[0.00011197273,0.00008771076,0.00014690582,0.00014106967,0.00012947925,0.00021005326,0.00023170564,0.0005454378,0.00043147456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019237954,0.000058280624,0.00013085571,0.00002408514,0.0000067695705,0.000020938349,0.000010238361,0.00018054074,0.9961009,0.00016331182,0.00011608993,0.002995547],"study_design_scores_gemma":[0.00001668135,0.00027408285,0.0010764089,0.0000023443815,0.000006879299,0.0001009064,0.0000105790305,0.00065634504,0.99552935,0.000050407823,0.0022738902,0.000002070591],"about_ca_topic_score_codex":0.0007924164,"about_ca_topic_score_gemma":0.001592462,"teacher_disagreement_score":0.0023826566,"about_ca_system_score_codex":0.00037607242,"about_ca_system_score_gemma":0.00022802265,"threshold_uncertainty_score":0.00797081},"labels":[],"label_agreement":null},{"id":"W4220684155","doi":"10.1016/j.omto.2022.03.006","title":"IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Virotherapy; Blockade; Immunotherapy; Cancer research; Monoclonal antibody; Interferon; Virology; Immunity; Immunology; Immune system; Virus; Biology; Antibody; Receptor","score_opus":0.010529561693263072,"score_gpt":0.26953644687245354,"score_spread":0.25900688517919046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220684155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913078,0.002462367,0.0024970777,0.00017422065,0.00014339229,0.00007287831,0.00027281,0.00015938655,0.0029101814],"genre_scores_gemma":[0.9955363,0.0008513627,0.0013696922,0.00007438025,0.000034211476,0.000060079834,0.00026926995,0.000015766458,0.0017889248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998425,0.000031190357,0.000013411656,0.000021712085,0.000034890585,0.000056175788],"domain_scores_gemma":[0.9999455,0.000014073215,0.000011114476,0.000008120181,0.000004013988,0.000017107766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015213511,0.00040932998,0.00040548525,0.00020899584,0.000118232994,0.00034954987,0.00021442049,0.00026418015,0.00130905],"category_scores_gemma":[0.0000850335,0.000103559316,0.0002626632,0.00012564265,0.0001932023,0.00021281793,0.00012410578,0.0009785887,0.0003186326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011144469,0.00059169147,0.00027216028,0.00007251121,0.000028198907,0.000049952137,0.0000229191,0.00068121427,0.9854118,0.00040443178,0.00029066566,0.011059994],"study_design_scores_gemma":[0.00023726045,0.0032989173,0.0019818335,0.0000090993635,0.0000379579,0.00025296595,0.00001784276,0.002693651,0.9869515,0.00014795955,0.004364506,0.000006473662],"about_ca_topic_score_codex":0.00031332893,"about_ca_topic_score_gemma":0.0008719662,"teacher_disagreement_score":0.00130905,"about_ca_system_score_codex":0.0003444898,"about_ca_system_score_gemma":0.00038524356,"threshold_uncertainty_score":0.0043791533},"labels":[],"label_agreement":null},{"id":"W4280561406","doi":"10.1016/j.omto.2022.04.004","title":"Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Ministère de l’Éducation, Gouvernement de l’Ontario; University of Ottawa; Terry Fox Research Institute; Canadian Cancer Society; Lotte and John Hecht Memorial Foundation; Colorado State University","keywords":"Oncolytic virus; Vanadate; Cancer research; Virotherapy; Sodium orthovanadate; Epidermal growth factor receptor; Kinase; Biology; Cell biology; Receptor; Biochemistry","score_opus":0.00979807380116661,"score_gpt":0.26120024497144595,"score_spread":0.25140217117027935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280561406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757474,0.003601893,0.00862246,0.0003406883,0.000099041186,0.00014401367,0.00064319465,0.00024441688,0.010556926],"genre_scores_gemma":[0.9948205,0.0006804044,0.001054894,0.000045153705,0.0000047942012,0.000024535859,0.00018866762,0.000023101042,0.0031580187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998037,0.000031849395,0.000013939524,0.000029377494,0.000059314294,0.00006173919],"domain_scores_gemma":[0.999926,0.000026764645,0.000013010849,0.000010551832,0.000012943993,0.000010702514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016465344,0.00024984303,0.00023821554,0.00016309976,0.00013232241,0.00046351727,0.0003289673,0.0002467861,0.002476683],"category_scores_gemma":[0.00020486854,0.00014317328,0.00020429934,0.000135219,0.0002287879,0.00025041107,0.00020840406,0.0005573595,0.00037031635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013289998,0.000035175482,0.00009385694,0.000036281275,0.0000065070394,0.000027255459,0.000011468582,0.0002661737,0.9969188,0.00053241657,0.0000729467,0.0018662097],"study_design_scores_gemma":[0.000007129078,0.00012552695,0.0007202593,0.0000023433902,0.000005369714,0.000082877305,0.000007869608,0.00077455956,0.99691796,0.00008444367,0.0012690474,0.000002648982],"about_ca_topic_score_codex":0.0014133232,"about_ca_topic_score_gemma":0.0025210548,"teacher_disagreement_score":0.002476683,"about_ca_system_score_codex":0.00048722647,"about_ca_system_score_gemma":0.00032868577,"threshold_uncertainty_score":0.008285344},"labels":[],"label_agreement":null},{"id":"W4303575247","doi":"10.1016/j.omto.2022.10.003","title":"Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada); St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Mitacs; Michael Smith Health Research BC; Canadian Cancer Society; University of British Columbia; Canadian Lung Association; British Columbia Lung Association","keywords":"Oncolytic virus; microRNA; Biology; Coding region; Genome; Virology; Reversion; Untranslated region; CRISPR; Virus; Coxsackievirus; Cancer research; Viral replication; Gene; Molecular biology; Computational biology; Genetics; Enterovirus; RNA; Phenotype","score_opus":0.027884358933590852,"score_gpt":0.30558367684842763,"score_spread":0.27769931791483676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303575247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991836,0.0009374116,0.005941063,0.000047807738,0.000030834017,0.000026386611,0.0003703017,0.000105402,0.00070481224],"genre_scores_gemma":[0.9903623,0.000447687,0.0065806983,0.000031188694,0.0000064348746,0.000030921732,0.0010534264,0.00006948253,0.0014178404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987626,0.000014129904,0.000012217479,0.00003158416,0.000044611967,0.000021142912],"domain_scores_gemma":[0.99987674,0.000018649544,0.000043581338,0.000015023579,0.000019387835,0.00002652018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021544698,0.0002609394,0.00020235757,0.00021229424,0.0001670002,0.00044958663,0.00020388079,0.00028614525,0.0005236816],"category_scores_gemma":[0.00023766384,0.00014861129,0.00024519034,0.0001612085,0.00016879143,0.00017866015,0.00017312962,0.00058301643,0.00022636572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038564434,0.00000809541,0.00007602408,0.000010814905,0.0000031553232,0.000012313739,0.000009795979,0.00006956755,0.9991177,0.000074547024,0.000015387666,0.00056410744],"study_design_scores_gemma":[0.000008887227,0.00015623943,0.0011025433,0.0000030322337,0.000012989511,0.00013936462,0.000008894646,0.0011044528,0.9950932,0.00003200902,0.0023320992,0.0000062399945],"about_ca_topic_score_codex":0.0008992463,"about_ca_topic_score_gemma":0.00079687877,"teacher_disagreement_score":0.0008992463,"about_ca_system_score_codex":0.0003621275,"about_ca_system_score_gemma":0.00017904861,"threshold_uncertainty_score":0.0026274323},"labels":[],"label_agreement":null},{"id":"W4319915108","doi":"10.1016/j.omto.2023.02.003","title":"Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"College of Medicine, University of Florida","keywords":"Oncolytic virus; Herpes simplex virus; Immune system; Virus; Cancer research; Biology; Viral replication; Carcinoembryonic antigen; Immunotherapy; Virology; Immunology; Cancer","score_opus":0.04717215919280651,"score_gpt":0.3268019723086337,"score_spread":0.27962981311582724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319915108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685791,0.0024622423,0.025529154,0.00010266297,0.000062957304,0.00008071998,0.00037868452,0.00024444208,0.0025600705],"genre_scores_gemma":[0.9876913,0.00058310776,0.008913473,0.000054793338,0.0000090020085,0.00004228113,0.00040490908,0.0000176849,0.0022836297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999058,0.000009118264,0.0000065075737,0.000024309296,0.0000326693,0.000021580554],"domain_scores_gemma":[0.99997306,0.0000026449695,0.000011224853,0.00000307003,0.000003573044,0.0000064401333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008894605,0.00029298765,0.00013104928,0.0001408256,0.00005487352,0.00028532583,0.00017187692,0.00018638314,0.00032301],"category_scores_gemma":[0.000060574297,0.000072523835,0.00017219975,0.00011583514,0.00016474153,0.00014195134,0.00018561665,0.0002829072,0.00014128964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052849075,0.000017254444,0.00012552511,0.000021983677,0.000002786049,0.000024640656,0.000004814183,0.00016614981,0.99675506,0.00019970041,0.000038121234,0.002591153],"study_design_scores_gemma":[0.000012765064,0.00029543732,0.0008444159,0.0000030348,0.000012537974,0.00027899296,0.0000061842006,0.0021468538,0.9932313,0.000054878587,0.00310871,0.0000048744732],"about_ca_topic_score_codex":0.00041853526,"about_ca_topic_score_gemma":0.00042085856,"teacher_disagreement_score":0.00041853526,"about_ca_system_score_codex":0.0003224439,"about_ca_system_score_gemma":0.00017448193,"threshold_uncertainty_score":0.002339542},"labels":[],"label_agreement":null},{"id":"W4321378595","doi":"10.1016/j.omto.2023.02.006","title":"Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies","year":2023,"lang":"en","type":"review","venue":"Molecular Therapy — Oncolytics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; University of Science and Technology of China; American Cancer Society","keywords":"Receptor tyrosine kinase; Cancer research; Medicine; Ovarian cancer; Targeted therapy; Cancer; Metastasis; Context (archaeology); Cabozantinib; Biology; Bioinformatics; Internal medicine; Receptor","score_opus":0.0893979594266115,"score_gpt":0.41769948961889636,"score_spread":0.32830153019228486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321378595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020557853,0.99853706,0.000117621166,0.0001720816,0.00011899539,0.000006239736,0.000020201078,0.000008433882,0.0008139463],"genre_scores_gemma":[0.0010455084,0.99793255,0.00016441892,0.00018256812,0.000090324436,0.000009045137,0.00003959043,0.0000016996183,0.00053429196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987805,0.000022624205,0.000014063787,0.000020432775,0.000050850264,0.000013959159],"domain_scores_gemma":[0.9998572,0.000063183834,0.00002167756,0.000004755434,0.000037684917,0.000015474918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004119015,0.00063725194,0.0010847424,0.001427266,0.00015253892,0.0006812915,0.00064193225,0.0006840853,0.002871736],"category_scores_gemma":[0.00041841037,0.00018802767,0.0004431506,0.0012768947,0.00028983902,0.00074191764,0.0005074363,0.0017163547,0.0015492677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011615361,0.00010721472,0.00011880791,0.011621368,0.000098577264,0.00014554859,0.00003793626,0.00048118446,0.0027176985,0.0029258858,0.020374924,0.96125466],"study_design_scores_gemma":[0.00006470323,0.00030193667,0.0007537163,0.003071862,0.00016261503,0.0012540608,0.000040410658,0.00020972482,0.00089316856,0.0014946735,0.9917355,0.000017578508],"about_ca_topic_score_codex":0.0005139844,"about_ca_topic_score_gemma":0.0011941134,"teacher_disagreement_score":0.002871736,"about_ca_system_score_codex":0.00041246024,"about_ca_system_score_gemma":0.0005169341,"threshold_uncertainty_score":0.009606838},"labels":[],"label_agreement":null},{"id":"W4363676920","doi":"10.1016/j.omto.2023.04.001","title":"Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Canada Research Chairs; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Somatostatin receptor; Oncolytic virus; Cancer research; Biodistribution; Vaccinia; Medicine; Somatostatin receptor 2; Receptor; Chemistry; Internal medicine; Biology; In vivo","score_opus":0.020962838391486664,"score_gpt":0.3293578608040862,"score_spread":0.30839502241259953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4363676920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871326,0.0031294485,0.005485846,0.0001718079,0.00009764573,0.00015296614,0.00011104215,0.00016651017,0.0019715119],"genre_scores_gemma":[0.9935436,0.0011107486,0.0041094176,0.000048532485,0.00003020105,0.00005521902,0.0001279583,0.00002712024,0.0009471787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999826,0.000046721176,0.00001573063,0.000032611133,0.000036040376,0.000042983193],"domain_scores_gemma":[0.99989593,0.000024908535,0.000029221066,0.000017275324,0.0000067052497,0.000025987152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028610407,0.0005619384,0.0005588013,0.0003503307,0.00010605677,0.0003397676,0.00025421576,0.00037243863,0.0005681127],"category_scores_gemma":[0.00020955257,0.00016993866,0.00037975053,0.00016635923,0.00031457888,0.00033116777,0.0002846593,0.00048672632,0.00015161335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005638945,0.00024728288,0.00027968045,0.00007747581,0.000022097836,0.000100615944,0.000022190989,0.00048376413,0.9885457,0.00030545588,0.00007296776,0.009278834],"study_design_scores_gemma":[0.00034557082,0.0071695847,0.0034171264,0.000010436312,0.000082088176,0.00080766215,0.000019803354,0.0038152314,0.9799882,0.00015715804,0.004174001,0.000013087857],"about_ca_topic_score_codex":0.00032449217,"about_ca_topic_score_gemma":0.00049470086,"teacher_disagreement_score":0.0005681127,"about_ca_system_score_codex":0.00024905626,"about_ca_system_score_gemma":0.0003477225,"threshold_uncertainty_score":0.0019005537},"labels":[],"label_agreement":null},{"id":"W4388153112","doi":"10.1016/j.omto.2023.100743","title":"Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Li Ka Shing Institute of Virology, University of Alberta; National Institutes of Health; Canada Research Chairs; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; Cure Brain Cancer Foundation; Emory University; University of Alberta; Faculty of Medicine and Dentistry, University of Alberta; Cancer Research Institute","keywords":"Oncolytic virus; Virus; Mutant; Cancer cell; Biology; Infectivity; Potency; Virology; Cancer; Cell culture; Cancer research; Myxoma virus; In vitro; Gene; Biochemistry; Genetics","score_opus":0.025957205564137865,"score_gpt":0.3273071999934433,"score_spread":0.30134999442930543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388153112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614596,0.00032440558,0.00278608,0.000030657986,0.000016962804,0.000014491755,0.00012597423,0.00004684558,0.0005085411],"genre_scores_gemma":[0.9957956,0.00020724964,0.0028878464,0.000015867265,0.00000252837,0.000009500491,0.00019687496,0.000029267703,0.00085526204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998934,0.000015298832,0.0000132182595,0.000021174392,0.00002806275,0.000028834324],"domain_scores_gemma":[0.99990606,0.000023382261,0.000028089771,0.000013054564,0.000009712567,0.000019699342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014651718,0.00037898117,0.00022230124,0.00017692927,0.000088060246,0.00028534213,0.00017896107,0.00035984843,0.00054432347],"category_scores_gemma":[0.00013521139,0.0001042668,0.0003051967,0.00012314373,0.00019400641,0.00018262501,0.000119810546,0.0005540171,0.0001480879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039010378,0.0000114235,0.00003711461,0.0000072341445,0.000002109589,0.000013634769,0.000004167282,0.000087460015,0.99945384,0.000055923556,0.000007861603,0.00028026974],"study_design_scores_gemma":[0.000005805922,0.00016499555,0.00039255808,0.0000016573613,0.0000072754683,0.00008803128,0.000004153399,0.00077133917,0.9981487,0.000012062903,0.00040075267,0.0000027584083],"about_ca_topic_score_codex":0.0013620269,"about_ca_topic_score_gemma":0.0010050251,"teacher_disagreement_score":0.0013620269,"about_ca_system_score_codex":0.00025813386,"about_ca_system_score_gemma":0.00021201976,"threshold_uncertainty_score":0.0027081966},"labels":[],"label_agreement":null},{"id":"W4388570838","doi":"10.1016/j.omto.2023.100748","title":"Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Society; University of Guelph","keywords":"Oncolytic virus; Immune system; Immunotherapy; Tumor microenvironment; Acquired immune system; Biology; Innate immune system; Ovarian cancer; Effector; Cancer research; Immunology; Immunity; Cancer immunotherapy; Cancer","score_opus":0.05008230310842119,"score_gpt":0.3473167769884998,"score_spread":0.29723447388007856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388570838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361527,0.0006416935,0.0047299946,0.000035181136,0.00001664353,0.00005547881,0.00034019974,0.00007850739,0.0004869868],"genre_scores_gemma":[0.9951645,0.0003650175,0.0030055689,0.000020119049,0.0000061230676,0.00007348043,0.00024560466,0.000017985287,0.0011016547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998969,0.000015444335,0.0000074122877,0.000019875562,0.000025463161,0.000034941037],"domain_scores_gemma":[0.9998952,0.000021064297,0.000039269722,0.000012890723,0.000009365107,0.000022242204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017262126,0.0002889743,0.00021873621,0.00033690638,0.00007827507,0.0001821612,0.00012428638,0.00026605977,0.0004813789],"category_scores_gemma":[0.00011387996,0.000115139155,0.0001895648,0.00014620763,0.0001852563,0.0002476946,0.000108077904,0.000646284,0.00013012659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021309912,0.000073322226,0.00021802928,0.000016576601,0.0000018883946,0.00001168875,0.000010053353,0.00026969585,0.99802256,0.0000759361,0.000013316257,0.0010738166],"study_design_scores_gemma":[0.000022797272,0.0012175486,0.0027442228,0.0000035424302,0.000007741616,0.00006677309,0.000015821417,0.003776179,0.9914233,0.000085034626,0.00063148217,0.000005476842],"about_ca_topic_score_codex":0.0003581156,"about_ca_topic_score_gemma":0.0003799396,"teacher_disagreement_score":0.0004813789,"about_ca_system_score_codex":0.00033104848,"about_ca_system_score_gemma":0.00018164466,"threshold_uncertainty_score":0.0024018884},"labels":[],"label_agreement":null},{"id":"W4389274134","doi":"10.1016/j.omto.2023.100754","title":"Gaining insights into virotherapy with canine models","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Université de Sherbrooke","keywords":"Oncolytic virus; Vesicular stomatitis virus; Osteosarcoma; Medicine; Oncology; Internal medicine; Context (archaeology); Cancer; Virotherapy; Cancer research; Virus; Immunology; Biology","score_opus":0.027806610463852466,"score_gpt":0.3065705279593866,"score_spread":0.27876391749553414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389274134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38746488,0.11730847,0.3523707,0.03258805,0.0046129744,0.0023574377,0.008764507,0.003373053,0.09115982],"genre_scores_gemma":[0.8263895,0.059137557,0.083227016,0.0031317854,0.00052876637,0.00091655547,0.0062556197,0.0005788286,0.01983443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928457,0.00025106533,0.000049971248,0.000113095826,0.00018775935,0.000113631846],"domain_scores_gemma":[0.9995376,0.00017891628,0.000061181774,0.00010938539,0.000053749107,0.00005929715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017236205,0.0005849473,0.0005882541,0.00095671864,0.00043699663,0.001467817,0.0007707095,0.0011429387,0.0040569305],"category_scores_gemma":[0.0010062912,0.000338675,0.000745219,0.0003392688,0.0010875325,0.0020746053,0.0008026184,0.003180096,0.001584636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010576621,0.0011400853,0.0019593826,0.0011773186,0.00012890516,0.00071357813,0.0005758289,0.00457724,0.8527152,0.061692383,0.01379377,0.060468614],"study_design_scores_gemma":[0.00025594037,0.005944122,0.004740416,0.0005079377,0.00020751347,0.004517612,0.00046182983,0.01935542,0.50609726,0.023486886,0.43430603,0.00011891747],"about_ca_topic_score_codex":0.0016019088,"about_ca_topic_score_gemma":0.0018050822,"teacher_disagreement_score":0.0040569305,"about_ca_system_score_codex":0.0016122935,"about_ca_system_score_gemma":0.00071982655,"threshold_uncertainty_score":0.013571799},"labels":[],"label_agreement":null}]}